These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1679613)

  • 1. Quantitation of plasma factor XIIIa activity using fibrin-coated microscopic latex beads.
    Retzinger GS; Cook BC; Smith RE; McGinnis MC
    Anal Biochem; 1991 May; 195(1):18-23. PubMed ID: 1679613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A turbidimetric method for measuring fibrin formation and fibrinolysis at solid-liquid interfaces.
    Retzinger GS; McGinnis MC
    Anal Biochem; 1990 Apr; 186(1):169-78. PubMed ID: 2192581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A turbidimetric assay for quantitating functional fibrin(ogen) using polystyrene-divinylbenzene microparticles.
    Cook BC
    Anal Biochem; 1999 May; 270(1):83-7. PubMed ID: 10328768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivity of human platelets with immobilized fibrinogen is dictated by the chemical character of the surface.
    Cook BC
    Thromb Res; 2001 Oct; 104(1):39-48. PubMed ID: 11583737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complexation with heparin prevents adhesion between fibrin-coated surfaces.
    Retzinger GS; Chandler LJ; Cook BC
    J Biol Chem; 1992 Dec; 267(34):24356-62. PubMed ID: 1447186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A turbidimetric method for measuring the activity of trypsin and its inhibition.
    Walker MB; Retzinger AC; Retzinger GS
    Anal Biochem; 2006 Apr; 351(1):114-21. PubMed ID: 16388777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of fibrinogen-coated, reversibly adhesive, lecithin/cholesterol vesicles.
    DeAnglis AP; Retzinger GS
    J Pharm Sci; 1995 Apr; 84(4):399-403. PubMed ID: 7629727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of fibrinogen carbamylation on fibrin clot formation and stability.
    Binder V; Bergum B; Jaisson S; Gillery P; Scavenius C; Spriet E; Nyhaug AK; Roberts HM; Chapple ILC; Hellvard A; Delaleu N; Mydel P
    Thromb Haemost; 2017 May; 117(5):899-910. PubMed ID: 28382370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic evaluation of factor XIIIa*-like enzyme activity in equine plasma as a potential therapeutic avenue for the inhibition of fibrinous tissue.
    Coyne CP; Smith JE; DeBowes RM
    Am J Vet Res; 1992 May; 53(5):695-705. PubMed ID: 1355954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of blood coagulation Factor XIIIa formation in plasma containing glycyl-L-prolyl-L-arginyl-L-proline.
    Miraglia CC; Greenberg CS
    Anal Biochem; 1985 Jan; 144(1):165-71. PubMed ID: 2858990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface-adsorbed fibrinogen and fibrin may activate the contact activation system.
    Sanchez J; Elgue G; Larsson R; Nilsson B; Olsson P
    Thromb Res; 2008; 122(2):257-63. PubMed ID: 18177925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The elasticity of an individual fibrin fiber in a clot.
    Collet JP; Shuman H; Ledger RE; Lee S; Weisel JW
    Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9133-7. PubMed ID: 15967976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal fibronectin 30-kDa fragment mediates the immobilization of soluble fibrin by factor XIIIa-coated polystyrene beads.
    Hörmann H; Richter H; Jelinić V; Wendt C
    Biol Chem Hoppe Seyler; 1987 Jun; 368(6):669-74. PubMed ID: 2887180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of fibrinogen D domain intermolecular association sites in the polymerization of fibrin and fibrinogen Tokyo II (gamma 275 Arg-->Cys).
    Mosesson MW; Siebenlist KR; DiOrio JP; Matsuda M; Hainfeld JF; Wall JS
    J Clin Invest; 1995 Aug; 96(2):1053-8. PubMed ID: 7635941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Lipid Surface Composition on the Formation and Structure of Fibrin Clots.
    Bakirova DR; Faizullin DA; Valiullina YA; Salnikov VV; Zuev YF
    Bull Exp Biol Med; 2017 Oct; 163(6):722-725. PubMed ID: 29063338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa.
    Schense JC; Hubbell JA
    Bioconjug Chem; 1999; 10(1):75-81. PubMed ID: 9893967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-assembly of soluble unlinked and cross-linked fibrin oligomers.
    Rosenfeld MA; Leonova VB; Biryukova MI; Vasileva MV
    Biochemistry (Mosc); 2011 Oct; 76(10):1155-63. PubMed ID: 22098241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of formation of factor XIIIa by its fibrin substrates.
    Lewis SD; Janus TJ; Lorand L; Shafer JA
    Biochemistry; 1985 Nov; 24(24):6772-7. PubMed ID: 2866798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
    Achyuthan KE; Dobson JV; Greenberg CS
    Biochim Biophys Acta; 1986 Aug; 872(3):261-8. PubMed ID: 2873839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.